Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
Vo Van Giau,1,* Hyon Lee,2,* Kyu Hwan Shim,1 Eva Bagyinszky,1 Seong Soo A An1 1Department of Bionano Technology, Gachon University, Seongnam, South Korea; 2Department of Neurology, Gachon University Gil Medical Center, Incheon, South Korea *These authors contributed equally to this work Abstract:...
Saved in:
Main Authors: | Giau VV, Lee H, Shim KH, Bagyinszky E, An SSA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/95bdeabb3b314e69a3cf6babb7dda1da |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
by: N. P. Peretolchina, et al.
Published: (2016) -
CRISPR and KRAS: a match yet to be made
by: Guzide Bender, et al.
Published: (2021) -
A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
by: Giau VV, et al.
Published: (2018) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
by: April Pawluk, et al.
Published: (2017) -
Characterization of a Type II-A CRISPR-Cas System in <italic toggle="yes">Streptococcus mutans</italic>
by: Cas Mosterd, et al.
Published: (2020)